Literature DB >> 15827330

8-Amino-adenosine induces loss of phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Akt kinase: role in induction of apoptosis in multiple myeloma.

Kulsoom Ghias1, Chunguang Ma, Varsha Gandhi, Leonidas C Platanias, Nancy L Krett, Steven T Rosen.   

Abstract

Multiple myeloma is a slowly proliferating B-cell malignancy that accumulates apoptosis-resistant and replication-quiescent cell populations, posing a challenge for current chemotherapeutics that target rapidly replicating cells. Multiple myeloma remains an incurable disease in need of new therapeutic approaches. The purine nucleoside analogue, 8-amino-adenosine (8-NH2-Ado), exhibits potent activity in preclinical studies, inducing apoptosis in several multiple myeloma cell lines. This cytotoxic effect requires phosphorylation of 8-NH2-Ado to its triphosphate form, 8-amino-ATP, and results in a concomitant loss of endogenous ATP levels. Here, we show the novel effect of 8-NH2-Ado on the phosphorylation status of key cellular signaling molecules. Multiple myeloma cells treated with 8-NH2-Ado exhibit a dramatic loss of phosphorylation of several important signaling proteins, including extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase, and Akt kinase. Cells depleted of ATP independent of 8-NH2-Ado do not exhibit the same decrease in phosphorylation of vital cellular proteins. Therefore, the significant shifts in endogenous ATP pools caused by 8-NH2-Ado treatment cannot account for the changes in phosphorylation levels. Instead, 8-NH2-Ado may influence the activity of select regulatory protein kinases and/or phosphatases, with preliminary data suggesting that protein phophatase 2A activity is affected by 8-NH2-Ado. The distinctive effect of 8-NH2-Ado on the phosphorylation status of cellular proteins is a novel phenomenon for a nucleoside analogue drug and is unique to 8-NH2-Ado among this class of drugs. The kinetics of 8-NH2-Ado-mediated changes in phosphorylation levels of critical prosurvival and apoptosis-regulating proteins suggests that the modulation of these proteins by dephosphorylation at early time points may be an important mechanistic step in 8-NH2-Ado-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827330     DOI: 10.1158/1535-7163.MCT-04-0303

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  16 in total

1.  Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

Authors:  Rathi N Pillai; Lisa S Chen; Mary L Ayres; Billie J Nowak; Michael W Thomas; Elizabeth J Shpall; Michael J Keating; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2012-04-23

2.  8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers.

Authors:  Alla Polotskaia; Sandy Hoffman; Nancy L Krett; Mala Shanmugam; Steven T Rosen; Jill Bargonetti
Journal:  Mol Cancer Ther       Date:  2012-09-12       Impact factor: 6.261

3.  ATP analog enhances the actions of a heat shock protein 90 inhibitor in multiple myeloma cells.

Authors:  Fabiola Cervantes-Gomez; Ramadevi Nimmanapalli; Varsha Gandhi
Journal:  J Pharmacol Exp Ther       Date:  2011-08-05       Impact factor: 4.030

4.  8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma.

Authors:  Jennifer B Dennison; Mala Shanmugam; Mary L Ayres; Jun Qian; Nancy L Krett; L Jeffrey Medeiros; Sattva S Neelapu; Steven T Rosen; Varsha Gandhi
Journal:  Blood       Date:  2010-09-15       Impact factor: 22.113

5.  An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.

Authors:  Lauren Averett Byers; Lixia Diao; Jing Wang; Pierre Saintigny; Luc Girard; Michael Peyton; Li Shen; Youhong Fan; Uma Giri; Praveen K Tumula; Monique B Nilsson; Jayanthi Gudikote; Hai Tran; Robert J G Cardnell; David J Bearss; Steven L Warner; Jason M Foulks; Steven B Kanner; Varsha Gandhi; Nancy Krett; Steven T Rosen; Edward S Kim; Roy S Herbst; George R Blumenschein; J Jack Lee; Scott M Lippman; K Kian Ang; Gordon B Mills; Waun K Hong; John N Weinstein; Ignacio I Wistuba; Kevin R Coombes; John D Minna; John V Heymach
Journal:  Clin Cancer Res       Date:  2012-10-22       Impact factor: 12.531

6.  8-Amino-adenosine inhibits multiple mechanisms of transcription.

Authors:  Jennifer Ann Frey; Varsha Gandhi
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

7.  Targeting glucose consumption and autophagy in myeloma with the novel nucleoside analogue 8-aminoadenosine.

Authors:  Mala Shanmugam; Samuel K McBrayer; Jun Qian; Kiril Raikoff; Michael J Avram; Seema Singhal; Varsha Gandhi; Paul T Schumacker; Nancy L Krett; Steven T Rosen
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

8.  Dual regulation of glucocorticoid-induced leucine zipper (GILZ) by the glucocorticoid receptor and the PI3-kinase/AKT pathways in multiple myeloma.

Authors:  Katharine D Grugan; Chunguang Ma; Seema Singhal; Nancy L Krett; Steven T Rosen
Journal:  J Steroid Biochem Mol Biol       Date:  2008-04-20       Impact factor: 4.292

9.  Chain termination and inhibition of mammalian poly(A) polymerase by modified ATP analogues.

Authors:  Lisa S Chen; Lei Du-Cuny; Vasupradha Vethantham; David H Hawke; James L Manley; Shuxing Zhang; Varsha Gandhi
Journal:  Biochem Pharmacol       Date:  2009-10-06       Impact factor: 5.858

10.  Intracellular succinylation of 8-chloroadenosine and its effect on fumarate levels.

Authors:  Jennifer B Dennison; Mary L Ayres; Kumar Kaluarachchi; William Plunkett; Varsha Gandhi
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.